Efficacy, Safety and Tolerability of BAF312 Compared to Placebo in Patients With Intracerebral Hemorrhage (ICH).

NCT03338998 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemorrhagic Stroke
Intracerebral Hemorrhage (ICH)

Interventions

DRUG: BAF312 solution
DRUG: Matching Placebo for BAF312 solution
DRUG: BAF312 tablet
DRUG: Matching Placebo for BAF312 tablet

Sponsor

Novartis Pharmaceuticals